Notably, the downregulation of PCK1 also promotes threonine O-GlcNAcylation of CHK2 at 378 site, compromising its stability and facilitating dimer formation, while also increasing CHK2-dependent Rb phosphorylation and proliferation of HCC cells (126). The gene discussed is CHEK2; the disease is hepatocellular carcinoma.